MMWR Morb Mortal Wkly Rep. 2014 Aug 15;63(32):691-7.
This report updates the 2013 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding use of seasonal influenza vaccines. Updated information for the 2014-15 influenza season includes 1) antigenic composition of U.S. seasonal influenza vaccines; 2) vaccine dose considerations for children aged 6 months through 8 years; and 3) a preference for the use, when immediately available, of live attenuated influenza vaccine (LAIV) for healthy children aged 2 through 8 years, to be implemented as feasible for the 2014-15 season but not later than the 2015-16 season. Information regarding issues related to influenza vaccination not addressed in this report is available in the 2013 ACIP seasonal influenza recommendations.
本报告更新了免疫实践咨询委员会(ACIP)关于使用季节性流感疫苗的 2013 年建议。针对 2014-15 流感季节的更新信息包括:1)美国季节性流感疫苗的抗原组成;2)6 个月至 8 岁儿童的疫苗剂量考虑因素;3)建议在有条件的情况下,为 2 至 8 岁健康儿童使用活减毒流感疫苗(LAIV),但不迟于 2015-16 流感季。本报告未涉及的与流感疫苗接种相关问题的信息,可在 2013 年 ACIP 季节性流感建议中获取。